Hologenix, LLC Completes Science Advisory Board
NEW YORK, April 19, 2012 /PRNewswire/ -- Hologenix, LLC, makers of Celliant, the leading innovative, responsive textile technology for apparel, body therapy, bedding and veterinary products, announces the completion of its Science Advisory Board and the establishment of their Research and Development Laboratory. The final two appointments to the Board are Dr. Lawrence A. Lavery (Diabetes and Wound Care) and Dr. Michael R. Hamblin (Photomedicine).
Currently a professor of surgery at University of Texas Southwestern Medical Center, Dr. Lavery is also the Vice Chair of Medical Affairs, Chronic Disease Specialists. He has served on the editorial board for Diabetes Care and has been published in more than 140 peer-reviewed publications. He is also the former chair of the American Diabetes Association Foot Care Council.
With over 30 years of experience, Dr. Hamblin is the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital and is an Associate Professor of Dermatology at Harvard Medical School. He is also a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. For the past seven years, Dr. Hamblin has chaired an annual conference at SPIE Photonics West entitled "Mechanisms for Low-Light Therapy."
Dr. Lavery and Dr. Hamblin join Dr. Christopher Drake (Sleep Medicine) and Dr. Shimon Weiss (Nanotechnology). Dr. Michael Coyle, Chief Science Officer for Hologenix, LLC, chairs the Science Advisory Board and provides expertise in Human Performance."We're thrilled to have such an impressive board of contributors," says Seth Casden, CEO of Hologenix, LLC. "Each member offers a wealth of knowledge in their respective field and will greatly assist us in our mission to develop products that improve the quality of people's lives." To coincide with its completion of the Science Advisory Board, Hologenix, LLC has established a Research and Development Laboratory, which has been approved to collect data for the purpose of generating original research for the peer-review process and publication. The Laboratory will work closely with the members of the Science Advisory Board, along with additional collaborators, to maximize its contributions.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV